Skip to main content

A Randomized, Double-Blind, Placebo-Controlled, Phase 4, Relapse Prevention Study Evaluating the Efficacy and Safety of Vortioxetine (5, 10 and 20 mg) in Adults With Major Depressive Disorder"

Clinical Trial Grant
Duke Scholars

Administered By

Psychiatry & Behavioral Sciences

Awarded By

Takeda Pharmaceuticals North America Inc.

Start Date

June 23, 2017

End Date

June 12, 2020
 

Administered By

Psychiatry & Behavioral Sciences

Awarded By

Takeda Pharmaceuticals North America Inc.

Start Date

June 23, 2017

End Date

June 12, 2020